Anondita Medicare IPO Turns Multibagger: 500% Gain in Just Months
Investors who received an allotment of Anondita Medicare shares appear to be rejoicing, as their IPO bets have turned into massive wealth creation, positioning the stock as one of the biggest wealth creators of 2025 despite heightened market volatility.
Stellar Debut and Continued Rally
The shares hit the secondary market in early September, listing at ₹275.50 apiece on the NSE SME platform, representing a sharp 90% premium to the issue price of ₹145. The stellar debut further strengthened momentum, with the stock continuing to hit the 5% upper circuit in subsequent sessions, driving the price up to ₹867, marking a nearly 500% gain over the IPO price.
An investor who received the minimum retail allotment of two lots, comprising 2,000 shares, and remained invested till date, the investment would have grown by about ₹17.34 lakh in under four months. To learn more about IPO investment strategies, click here.
Best-Performing SME IPOs of 2025
The massive rally has also placed the stock among the best-performing SME IPOs of 2025 so far. According to Trendlyne data, 260 SME issues have entered the Indian stock market till December 24, higher than 247 in 2024 and 177 in 2023.
Despite another record-breaking year for IPOs, post-listing performance has remained unimpressive. As many as 135 stocks, or nearly 50% of the 366 total issues (including mainboard IPOs), are currently trading below their issue prices. For more information on SME IPOs, visit our website.
Anondita Medicare IPO Details
The Anondita Medicare IPO witnessed stellar investor demand, closing with a 301 times subscription at the end of the three-day bidding process.
The retail investor portion was subscribed 286.20 times, while the qualified institutional buyer (QIB) segment saw bids 153.03 times the shares on offer. The non-institutional investor (NII) quota was the most aggressive, with a 531.82-times subscription.
Overall, the SME IPO received bids for 95,47,28,000 shares, against 31,73,000 shares on offer. The ₹69.50-crore IPO was entirely a fresh issue of 0.48 crore shares, priced in the range of ₹137–145 per share.
The public issue opened for subscription on August 22, 2025, and closed on August 26, 2025. The allotment was finalized on August 28. Proceeds from the issue will be utilised for the purchase of equipment and machinery, working capital requirements, acquisitions, and general corporate purposes. To know more about IPO allotment process, click here.
About Anondita Medicare
Incorporated in March 2024, Anondita Medicare Limited manufactures flavored male condoms under its flagship brand “COBRA.” The company has an annual production capacity of 562 million condoms, with its manufacturing facility located in Noida, Uttar Pradesh.
The company also exports its products to international markets, including Southeast Asia, Africa, and the Middle East. For more information on pharmaceutical industry trends, visit our website.
Conclusion
Anondita Medicare’s IPO has been a remarkable success, with the stock turning into a multibagger in just a few months. The company’s strong fundamentals and growth prospects have made it an attractive investment opportunity for investors. However, it’s essential to remember that the stock market can be volatile, and investors should always do their research and consult with a financial advisor before making any investment decisions. To stay updated with the latest stock market news and trends, follow our website.